Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000006080
http://purl.bioontology.org/ontology/NDFRT/N0000006080
|
|---|---|
| Preferred Name | Cytarabine [Chemical/Ingredient] |
| Synonyms |
Arabinosylcytosine
Aracytidine
2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
Cytosine Arabinoside
Arabinofuranosylcytosine
Cytarabine
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
Arabinosylcytosine
Aracytidine
2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
Cytosine Arabinoside
Arabinofuranosylcytosine
Cytarabine
See more
See less
|
|---|---|
| prefLabel | Cytarabine [Chemical/Ingredient]
|
| MESH DEFINITION | A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
|
| MESH DUI | D003561
|
| MESH UI | M0005564
|
| MeSH name | Cytarabine
|
| type | |
| tui |
T114
T121
|
| notation | N0000006080
|
| Semantic type UMLS property | |
| NUI | N0000006080
|
| Ingredient of |
See more
See less
|
| cui | C0010711
|
| NDFRT kind | INGREDIENT_KIND
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |